Cargando…
PON2 ameliorates Ang II‐induced cardiomyocyte injury by targeting the CANX/NOX4 signaling pathway
BACKGROUND: The incidence of heart failure (HF) presents an escalating trend annually, second only to cancer. Few literatures are available regarding on the role of paraoxonase 2 (PON2) in HF so far despite the protective role of PON2 in cardiovascular diseases. METHODS: PON2 expression in AC16 cell...
Autores principales: | Ye, Yuanzheng, Zhang, Jian, Guo, Yankai, Zhu, Jiajun, Tang, Baopeng, Fan, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910164/ https://www.ncbi.nlm.nih.gov/pubmed/36840500 http://dx.doi.org/10.1002/iid3.765 |
Ejemplares similares
-
Overexpression of NOX2 Exacerbates AngII-Mediated Cardiac Dysfunction and Metabolic Remodelling
por: Hansen, Synne S., et al.
Publicado: (2022) -
Effect of ligustilide on Ang II-induced hypertrophy in cardiomyocytes and the potential mechanisms
por: LU, QUN, et al.
Publicado: (2014) -
Novel Therapeutic Effects of Pterosin B on Ang II-Induced Cardiomyocyte Hypertrophy
por: Lee, Chang Youn, et al.
Publicado: (2020) -
EPC-Derived Microvesicles Protect Cardiomyocytes from Ang II-Induced Hypertrophy and Apoptosis
por: Gu, Shenhong, et al.
Publicado: (2014) -
Cardioprotective effects of Moku-boi-to and its impact on AngII-induced cardiomyocyte hypertrophy
por: Tagashira, Hideaki, et al.
Publicado: (2023)